Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 May;118(2):205–207. doi: 10.1111/j.1476-5381.1996.tb15387.x

The effect of nociceptin on Ca2+ channel current and intracellular Ca2+ in the SH-SY5Y human neuroblastoma cell line.

M Connor 1, A Yeo 1, G Henderson 1
PMCID: PMC1909632  PMID: 8735615

Abstract

The human neuroblastoma cell line SH-SY5Y expresses the 'orphan' opioid receptor (ORL1). We have demonstrated that nociceptin, the putative endogenous ligand for ORL1, produces a concentration-dependent inhibition of the N-type calcium channel current in these cells (IC50 42 nM). In addition, in the presence of carbachol, nociceptin increased the intracellular concentration of Ca2+ (EC50 60 nM). Both effects of nociceptin were blocked by pertussis toxin pretreatment but not by the opioid antagonists CTAP (1 microM), naltrindole (1 microM) and naloxone (10 microM).

Full text

PDF
206

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cheng J., Standifer K. M., Tublin P. R., Su W., Pasternak G. W. Demonstration of kappa 3-opioid receptors in the SH-SY5Y human neuroblastoma cell line. J Neurochem. 1995 Jul;65(1):170–175. doi: 10.1046/j.1471-4159.1995.65010170.x. [DOI] [PubMed] [Google Scholar]
  2. Kennedy C., Henderson G. Chronic exposure to morphine does not induce dependence at the level of the calcium channel current in human SH-SY5Y cells. Neuroscience. 1992 Aug;49(4):937–944. doi: 10.1016/0306-4522(92)90369-d. [DOI] [PubMed] [Google Scholar]
  3. Meunier J. C., Mollereau C., Toll L., Suaudeau C., Moisand C., Alvinerie P., Butour J. L., Guillemot J. C., Ferrara P., Monsarrat B. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature. 1995 Oct 12;377(6549):532–535. doi: 10.1038/377532a0. [DOI] [PubMed] [Google Scholar]
  4. Mollereau C., Parmentier M., Mailleux P., Butour J. L., Moisand C., Chalon P., Caput D., Vassart G., Meunier J. C. ORL1, a novel member of the opioid receptor family. Cloning, functional expression and localization. FEBS Lett. 1994 Mar 14;341(1):33–38. doi: 10.1016/0014-5793(94)80235-1. [DOI] [PubMed] [Google Scholar]
  5. Reinscheid R. K., Nothacker H. P., Bourson A., Ardati A., Henningsen R. A., Bunzow J. R., Grandy D. K., Langen H., Monsma F. J., Jr, Civelli O. Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor. Science. 1995 Nov 3;270(5237):792–794. doi: 10.1126/science.270.5237.792. [DOI] [PubMed] [Google Scholar]
  6. Seward E., Hammond C., Henderson G. Mu-opioid-receptor-mediated inhibition of the N-type calcium-channel current. Proc Biol Sci. 1991 May 22;244(1310):129–135. doi: 10.1098/rspb.1991.0061. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES